Key result
EMCV-B1 does not induce detectable levels of interferon but retains the ability to interfere with the production of insulin-dependent diabetes mellitus by EMCV-D in ICR Swiss male mice.
Population
ICR Swiss male mice and cell culture
Comparison
Infection with EMCV-B1 vs EMCV-D alone (implied)
Design
Preclinical
Authors
Loading...
Non-interferon mechanisms protect beta cells from EMCV-D diabetes in mice; leaves open relevance to human type 1 diabetes.
Protection of pancreatic beta cells in ICR Swiss mice by EMCV-B against EMCV-D-induced diabetes occurs by a mechanism other than interferon production.
Giron et al. (1993) studied Insulin-dependent diabetes mellitus (IDDM). EMCV-B1 (subvariant of benign EMCV-B) vs. EMCV-D alone was evaluated on Production of detectable levels of IFN and interference with IDDM production by EMCV-D. EMCV-B1 does not induce detectable levels of interferon but retains the ability to interfere with the production of insulin-dependent diabetes mellitus by EMCV-D in ICR Swiss male mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: